Shanghai Henlius Biotech   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Shanghai China (2009)
Status: No NME R&D (2009)

Organization Overview

First Clinical Trial
2014
NCT03218072
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Shanghai Henlius Biotech